Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) shares reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $11.47 and last traded at $11.00, with a volume of 650688 shares trading hands. The stock had previously closed at $10.50.
Cybin Stock Up 4.8 %
The company has a market cap of $1.63 billion and a P/E ratio of -43.75. The business has a fifty day moving average of $7.87 and a 200 day moving average of $2.95.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
See Also
- Five stocks we like better than Cybin
- EV Stocks and How to Profit from Them
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- NYSE Stocks Give Investors a Variety of Quality Options
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- The 3 Best Retail Stocks to Shop for in August
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
